- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05489484
Performance and Safety Evaluation of MD-Shoulder Collagen Medical Device in the Treatment of Rotator Cuff Syndrome (ROPIRAMED)
Performance and Safety Evaluation of Type I Collagen (MD-Shoulder Collagen Medical Device) in the Treatment of Rotator Cuff Syndrome ''ROPIRAMED PILOT STUDY''
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is a pilot monocentric Clinical Investigation based on a one sample design. The purpose of this research is to evaluate, through the CMS functional scale, the performance of intra-articular treatment with a collagen-based medical device in recovering joint function and reducing associated pain. The safety of the treatment will also be assessed. Variables will be assessed at 6 different times points: at baseline (day0), after weeks 2, weeks 4, months 3, months 6, and after months 12.
The total duration of the study will be 16 months. There will be a 4-month subject selection and recruitment period and a 12-month treatment and observation period.
A total of 24 subjects with painful shoulder in Rotator Cuff Syndrome will be enrolled. The recruitment phase will be closed no sooner than the number of subjects planned in the study has been reached. Enrollment will involve subjects with rotator cuff syndrome who are eligible according to the selection criteria. Diagnosis will be performed by the Principal Investigator through clinical examination and instrumental investigation with shoulder MRI. The investigators will explain the rationale for the investigation plan and the procedures involved to the eligible subjects. Consent to participate in the study will then be sought. Prior or ongoing the treatments of any kind will be documented.
In order to monitor analgesic consumption (Celecoxib 200mg / Paracetamol 1000 mg) used during the study in case of pain onset, a clinical diary will be given to the subject in which to indicate the day and dose of medication used.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Miranda MV Vincenzo, Dr
- Phone Number: +39 3351311917
- Email: v.miranda@guna.it
Study Contact Backup
- Name: Kamilia LK Laarej, Dr
- Phone Number: +39 0228018359
- Email: k.laarej@guna.it
Study Locations
-
-
MI
-
Milan, MI, Italy, 20122
- Recruiting
- Gaetano Pini CTO
-
Contact:
- Randelli RPS Pietro Simone, Prof.
- Phone Number: +39 3355292622
- Email: pietro.randelli@unim.it
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Subjects with age > 18 years.
- Subjects with shoulder pain for at least 3 month.
- Subjects with a diagnosis of rotator cuff tendinopathy, subacromial conflict syndrome, partial rotator cuff tendon injuries (injuries A and B according to Snyder's Classification).
- Subjects with a CMS score between 40 and 75.
- Subjects who understood and signed the Informed Consent to Active Participation in the study.
- Subjects able to understand the conditions of the study and participate throughout the duration.
Exclusion Criteria:
- Subjects with complete rotator cuff lesions (C lesions according to Snyder's classification).
- Subjects with shoulder instability.
- Subjects with adhesive retractile capsulitis.
- Subjects undergoing Hyaluronic Acid and/or cortisone infiltration in a period < 3 months.
- Subjects with diabetes mellitus.
- Subjects with uncontrolled thyroid disease.
- Subjects with coagulopathies.
- Subjects on chronic treatment with immunosuppressants.
- Subjects with an allergy to porcine collagen.
- Subjects in pregnancy or lactation.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: MD-Shoulder Medical Device
MD-Shoulder Medical Device type I collagen based
|
Only one experimental group is scheduled by the Investigation Plan to be treated with 2-mL volume ultrasound-guided infiltrations of MD-Shoulder Collagen Medical Device (GUNA, Milan-Italy). Subjects will be treated with number one ultrasound-guided infiltration at the time of enrollment, 2 weeks after enrollment, and 4 weeks after enrollment. Intra-articular infiltrations will be performed with 5cc syringes and 22-gauge needles. MD-Shoulder Collagen Medical Device will be infiltrated within the scapulohumeral joint under conditions of complete asepsis. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evaluation, using the Constant-Murley Functional Scale (CMS), score ranges from 0 to 100 points, representing worst and best shoulder function respectively.
Time Frame: months 3
|
The primary End Point will consist of evaluating, through the Constant-Murley Score (CMS), the effectiveness, in terms of performance, of MD-Shoulder Collagen Medical Device in recovering joint function and reducing associated pain at months 3, compared with day 0.
An increase of at least 13 points on the CMS scale is considered clinically significant.
|
months 3
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evaluation of MD-Shoulder Collagen Medical Device with Numeric Rating Scale the number between 0 and 10, zero usually represents 'no pain at all' whereas the upper limit represents 'the worst pain ever possible'.
Time Frame: weeks 2, weeks 4, months 3, months 6, months 12
|
Secondary Endpoints will consist of the evaluation of MD-Shoulder Collagen Medical Device, with NRS (Numeric Rating Scale) at weeks 2, weeks 4, months 3, mouth 6, mouth 12 compared to day 0.
|
weeks 2, weeks 4, months 3, months 6, months 12
|
Evaluation of MD-Shoulder Collagen Medical Device with American Shoulder and Elbow Surgeons (ASES)Scores range from 0 to 100 with a score of 0 indicating a worse shoulder condition and 100 indicating a better shoulder condition
Time Frame: months 3 months 6, months 12
|
Secondary Endpoints will consist of the evaluation of MD-Shoulder Collagen Medical with American Shoulder and Elbow Surgeons (ASES), Simply Shoulder Test (SST) and Range Of Motion (ROM) at months 3, mouth 6, mouth 12 compared to day 0
|
months 3 months 6, months 12
|
Evaluation of MD-Shoulder Collagen Medical Device with simply shoulder test (SST), the items on the scale measure the ability of the affected shoulder to perform work duties, dressing, bathing, lifting, carrying and throwing.
Time Frame: months 3, months 6, months12
|
Secondary Endpoints will consist of the evaluation of MD-Shoulder Collagen Medical Device with simply shoulder test (SST) at months 3, mouth 6, mouth 12 compared to day 0 number of "yes"/number of completed items 100 = % of "yes" response. 0 = worst and 100 = best function |
months 3, months 6, months12
|
Evaluation of MD-Shoulder Collagen Medical Device with range of motion (ROM) with goniometers measure range of motion in degrees, from zero to 180 or 360, and come in various shapes and sizes to be used on particular joints.
Time Frame: months 3, months 6, months12
|
Secondary Endpoints will consist of the evaluation of MD-Shoulder Collagen Medical with Range Of Motion (ROM) at months 3, mouth 6, mouth 12 compared to day 0
|
months 3, months 6, months12
|
Evaluation of MD-Shoulder Collagen Medical with assessment of analgesic drug unit consumption based on clinical diary at various phases of the study.
Time Frame: months 3, months 6, months 12
|
Secondary Endpoints will consist of the evaluation of MD-Shoulder Collagen Medical with Analgesic consumption at various phases of the study with use of clinical diary
|
months 3, months 6, months 12
|
Evaluation of Adverse Events.
Time Frame: weeks 2, weeks 4, months 3, months 6, months 12
|
Evaluation of Adverse Events.
|
weeks 2, weeks 4, months 3, months 6, months 12
|
Evaluation of MD-Shoulder Collagen Medical Device performance using the Constant-Murley from 0 to 100 points, representing worst and best shoulder function respectively.
Time Frame: months 6, months12
|
Secondary Endpoints will consist of the evaluation of MD-Shoulder Collagen Medical device through CMS at months 6 and months 12 compared to day 0.
|
months 6, months12
|
Evaluation of MD-Shoulder Collagen Medical with cuff integrity at mouth 12 compared to day 0 by performing with Magnetic Resonance Imaging (MRI) of the treated shoulder.
Time Frame: month 12
|
Secondary Endpoints will consist of the evaluation of MD-Shoulder Collagen Medical with cuff integrity at mouth 12 compared to day 0 by performing with Magnetic Resonance Imaging (MRI) of the treated shoulder.
|
month 12
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Randelli RP Pietro Simone, Prof, Gaetano Pini CTO
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MDG2021184
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Rotator Cuff Injuries
-
The Cleveland ClinicRecruitingRotator Cuff Tears | Rotator Cuff RepairsUnited States
-
Bezmialem Vakif UniversityNot yet recruitingRotator Cuff Tears | Partial Tear of Rotator CuffTurkey
-
Xiros LtdNot yet recruitingRotator Cuff Tear | Rotator Cuff Injuries | Rotator Cuff Tears | Rotator Cuff Tears of the Shoulder
-
Spital Thurgau AGRecruiting
-
CONMED CorporationRecruitingRotator Cuff TearsUnited States
-
The University of Texas Health Science Center,...Skye BiologicsNot yet recruiting
-
Peking University Third HospitalRecruiting
-
Kaohsiung Veterans General Hospital.Recruiting
-
University of CalgaryRecruiting
-
Seoul National University Bundang HospitalMinistry of Health, Republic of KoreaRecruitingRotator Cuff TearsKorea, Republic of
Clinical Trials on MD-Shoulder Collagen Medical Device
-
Guna S.p.aTerminatedGreater Trochanteric Pain Syndrome | Pertrochanteric Fracture | Gluteal Tendinitis | GTPS - Greater Trochanteric Pain Syndrome | Tendon Disorder | Gluteal MusclesItaly
-
Guna S.p.aRecruitingTendinopathy | Achilles Tendinopathy | Insertional Achilles Tendinopathy | PeritendinitisItaly
-
GenSight BiologicsRecruitingNon-syndromic Retinitis PigmentosaUnited States, France, United Kingdom
-
Gazi UniversityCompletedWound Heal | Palate; Wound | Graft Pain
-
Medical University of LodzBaxter Healthcare CorporationUnknownCHD - Coronary Heart DiseasePoland
-
South China Research Center for Stem Cell and Regenerative...UnknownBurns | Diabetic Foot Ulcers | Wounds
-
Karolinska University HospitalCompleted
-
SeptodontSymatese; ReCOL; EndoDataCompletedOral HemorrhageBelgium, France
-
Fondazione Don Carlo Gnocchi OnlusFondazione Ico FalckNot yet recruitingMultiple Sclerosis | Parkinson Disease | Post-stroke
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); University of MinnesotaCompletedCurrent Every Day Smoker | Cigarette SmokerUnited States